Short Interest in Senestech, Inc. (NASDAQ:SNES) Declines By 43.7%

Senestech, Inc. (NASDAQ:SNES) saw a large drop in short interest in the month of March. As of March 13th, there was short interest totaling 27,834 shares, a drop of 43.7% from the February 26th total of 49,411 shares. Approximately 0.6% of the shares of the company are short sold. Based on an average daily trading volume, of 59,377 shares, the short-interest ratio is currently 0.5 days.

Insider Transactions at Senestech

In other news, major shareholder Glenbrook Capital Management purchased 19,725 shares of the stock in a transaction dated Tuesday, March 17th. The shares were purchased at an average cost of $1.79 per share, with a total value of $35,307.75. Following the completion of the acquisition, the insider owned 890,635 shares in the company, valued at $1,594,236.65. This represents a 2.26% increase in their position. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. Over the last quarter, insiders have acquired 344,988 shares of company stock worth $697,208. Insiders own 5.29% of the company’s stock.

Institutional Investors Weigh In On Senestech

Institutional investors have recently made changes to their positions in the business. XTX Topco Ltd bought a new position in shares of Senestech in the fourth quarter worth approximately $54,000. Sabby Management LLC raised its holdings in Senestech by 195.4% during the 4th quarter. Sabby Management LLC now owns 210,564 shares of the company’s stock valued at $451,000 after buying an additional 139,281 shares during the last quarter. Jane Street Group LLC bought a new stake in Senestech during the 4th quarter valued at $32,000. DRW Securities LLC grew its holdings in Senestech by 171.1% in the 4th quarter. DRW Securities LLC now owns 82,107 shares of the company’s stock worth $176,000 after acquiring an additional 51,818 shares during the last quarter. Finally, Renaissance Technologies LLC increased its position in shares of Senestech by 35.2% in the fourth quarter. Renaissance Technologies LLC now owns 142,800 shares of the company’s stock valued at $306,000 after acquiring an additional 37,165 shares during the period. Hedge funds and other institutional investors own 5.19% of the company’s stock.

Senestech Price Performance

SNES stock traded down $0.07 during mid-day trading on Friday, hitting $1.67. 22,756 shares of the stock were exchanged, compared to its average volume of 55,915. The business has a fifty day moving average price of $2.00 and a 200 day moving average price of $2.81. Senestech has a 12 month low of $1.30 and a 12 month high of $6.24. The company has a debt-to-equity ratio of 0.02, a current ratio of 12.61 and a quick ratio of 11.36. The stock has a market capitalization of $8.85 million, a price-to-earnings ratio of -0.60 and a beta of 0.15.

Senestech (NASDAQ:SNES) last announced its quarterly earnings data on Thursday, March 12th. The company reported ($0.29) EPS for the quarter, beating the consensus estimate of ($0.30) by $0.01. The firm had revenue of $0.42 million for the quarter, compared to analyst estimates of $0.78 million. Senestech had a negative return on equity of 78.74% and a negative net margin of 287.39%. On average, sell-side analysts anticipate that Senestech will post -10.22 EPS for the current year.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings reissued a “sell (e+)” rating on shares of Senestech in a research note on Monday, December 29th. One analyst has rated the stock with a Strong Buy rating, one has given a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, Senestech has an average rating of “Hold”.

Senestech Company Profile

SenesTech, Inc (NASDAQ: SNES) is a biotechnology company specializing in non-lethal pest management solutions. The company’s core focus is the development and commercialization of fertility-based control methods for commensal rodents, providing an alternative to traditional rodenticides. By targeting the reproductive cycle of rats, SenesTech aims to reduce rodent populations over time without the use of toxic chemicals, offering a more sustainable approach for pest management professionals.

The company’s flagship product, ContraPest®, is an EPA-registered liquid bait that disrupts rodent reproduction.